CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer.
Shehwana H, Keskus AG, Ozdemir SE, Acikgöz AA, Biyik-Sit R, Cagnan I, Gunes D, Jahja E, Cingir-Koker S, Olmezer G, Sucularli C, Konu O.
Shehwana H, et al. Among authors: cagnan i.
Cell Oncol (Dordr). 2021 Apr;44(2):453-472. doi: 10.1007/s13402-020-00581-x. Epub 2021 Jan 19.
Cell Oncol (Dordr). 2021.
PMID: 33469842